The MMRV vaccine, approved in 2005, carries a slightly higher risk of febrile seizures in toddlers aged 12 to 15 months compared to separate MMR and V doses. Analyses show an additional one febrile seizure per 2,300 to 2,600 children receiving the combined MMRV as a first dose. These seizures are generally harmless and do not result in long-term effects.

Despite this slight increase, the Advisory Committee on Immunization Practices (ACIP) recommended the separate MMR + V combination in 2009. However, the MMRV vaccine remained an option for parents consulting with doctors, with no new data altering expert views since then. This recommendation aimed to minimize even minor risks for young children.

Data from King County between 2015 and 2025 reveals that 15 percent of children still received the MMRV vaccine as their first dose, contrary to recommendations. This group disproportionately included children from minority racial and ethnic groups, those receiving catch-up doses outside the recommended window, and children eligible for federally funded vaccines for low-income families, often receiving them at safety-net clinics.